Earnings Call · Q1 FY2024·2024-05-09

Q1 24EPS +9.72%·Rev n/aQ4 23EPS +25.84%·Rev n/aQ3 23EPS +30.11%·Rev n/aQ2 23EPS +28.57%·Rev n/a⚠ consensus missing

LISATA THERAPEUTICS, INC. LSTA

John Menditto — Vice President

David Mazzo — President and Chief Executive Officer

James Nisco — Financial Officer (likely Chief Financial Officer or similar)

Kristen Buck — Executive (likely Executive Vice President or similar)

+1.3%1d on move date+1.1% vs SPY3d+1.6%5d−3.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LSTA calls or request research access.

More LSTA calls Browse calls Request research access